Gsa Capital Partners LLP Abb Vie Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $590,694 - $673,041	-3,696 Reduced 55.49%	2,965 $539,000
Q4 2023 Feb 16, 2024	BUY	$137.6 - $154.97 $916,553 - $1.03 Million	6,661 New	6,661 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.04 Million - $1.3 Million	7,876 New	7,876 $1.06 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $205,191 - $260,865	1,491 New	1,491 $228,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $391,020 - $443,866	-3,675 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $386,646 - $430,746	3,675 New	3,675 $414,000
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $228,591 - $308,622	-2,840 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $243,984 - $286,357	2,840 New	2,840 $249,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $375,801 - $502,877	-5,122 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $729,172 - $1.11 Million	-11,305 Reduced 68.82%	5,122 $390,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $896,359 - $1.12 Million	12,427 Added 310.68%	16,427 $1.45 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1.86 Million - $2.24 Million	-29,568 Reduced 88.08%	4,000 $303,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $2.21 Million - $2.82 Million	33,568 New	33,568 $2.44 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $903,059 - $1.11 Million	-11,600 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $92,644 - $102,991	-1,042 Reduced 8.24%	11,600 $1.1 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $3.98 Million - $4.71 Million	-44,366 Reduced 77.82%	12,642 $1.17 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $5.25 Million - $7.02 Million	57,008 New	57,008 $5.4 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $283,726 - $311,129	-3,168 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$69.85 - $89.22 $221,284 - $282,648	3,168	3,168 $282,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account